Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionbeta-catenin binding

DLG5 AMER3 SUFU SHROOM2

1.81e-04120474GO:0008013
DomainVWFA

INTS6 MDN1 HMCN2 SVEP1

6.29e-0582494PS50234
DomainVWA

INTS6 MDN1 HMCN2 SVEP1

6.91e-0584494SM00327
DomainVWF_A

INTS6 MDN1 HMCN2 SVEP1

1.31e-0499494IPR002035
DomainDUF1220

NBPF4 NBPF6

2.40e-049492SM01148
DomainCUB

DMBT1 CSMD1 TMPRSS7

2.87e-0449493PF00431
DomainCUB

DMBT1 CSMD1 TMPRSS7

3.05e-0450493SM00042
Domain-

DMBT1 CSMD1 TMPRSS7

3.43e-04524932.60.120.290
DomainCUB

DMBT1 CSMD1 TMPRSS7

3.62e-0453493PS01180
DomainNBPF_dom

NBPF4 NBPF6

3.65e-0411492IPR010630
DomainNBPF

NBPF4 NBPF6

3.65e-0411492PS51316
DomainDUF1220

NBPF4 NBPF6

3.65e-0411492PF06758
DomainCUB_dom

DMBT1 CSMD1 TMPRSS7

4.49e-0457493IPR000859
DomainEGF_1

HGFAC HMCN2 LAMA3 SSPOP SVEP1

5.33e-04255495PS00022
DomainEGF_2

HGFAC HMCN2 LAMA3 SSPOP SVEP1

6.34e-04265495PS01186
DomainIG

IGFN1 CD7 HMCN2 KIR3DL3 KIR2DL4 NFAM1

7.80e-04421496SM00409
DomainIg_sub

IGFN1 CD7 HMCN2 KIR3DL3 KIR2DL4 NFAM1

7.80e-04421496IPR003599
Domain-

INTS6 MDN1 SVEP1

9.65e-04744933.40.50.410
DomainIG_LIKE

IGFN1 CD7 HMCN2 KIR3DL3 KIR2DL4 NFAM1

1.72e-03491496PS50835
Domain-

SHBG LAMA3 SVEP1

1.98e-03954932.60.120.200
DomainCARD

DLG5 RIPK2

2.99e-0331492IPR001315
DomainEGF_3

HGFAC HMCN2 SSPOP SVEP1

3.32e-03235494PS50026
DomainCARD

DLG5 RIPK2

3.38e-0333492PS50209
DomainEF-hand_8

NECAB2 CALML6

3.59e-0334492PF13833
DomainMyb_DNA-binding

MIDEAS MYB

3.80e-0335492PF00249
DomainEGF-like_dom

HGFAC HMCN2 LAMA3 SVEP1

4.08e-03249494IPR000742
DomainMYB_LIKE

MIDEAS MYB

4.46e-0338492PS50090
DomainLAM_G_DOMAIN

SHBG LAMA3

4.46e-0338492PS50025
DomainUQ_con

UBE2J1 BIRC6

4.70e-0339492PF00179
DomainEGF-like_CS

HGFAC HMCN2 LAMA3 SVEP1

4.82e-03261494IPR013032
DomainLDLR_class-A_CS

TMPRSS7 SSPOP

4.94e-0340492IPR023415
DomainUBIQUITIN_CONJUGAT_1

UBE2J1 BIRC6

4.94e-0340492PS00183
DomainUBQ-conjugat_E2

UBE2J1 BIRC6

5.18e-0341492IPR000608
DomainUBIQUITIN_CONJUGAT_2

UBE2J1 BIRC6

5.18e-0341492PS50127
DomainLamG

SHBG LAMA3

5.95e-0344492SM00282
DomainLdl_recept_a

TMPRSS7 SSPOP

6.21e-0345492PF00057
Domain-

TMPRSS7 SSPOP

6.48e-03464924.10.400.10
DomainLDLRA_1

TMPRSS7 SSPOP

7.04e-0348492PS01209
DomainLDLRA_2

TMPRSS7 SSPOP

7.33e-0349492PS50068
DomainLDrepeatLR_classA_rpt

TMPRSS7 SSPOP

7.33e-0349492IPR002172
DomainLDLa

TMPRSS7 SSPOP

7.33e-0349492SM00192
DomainSANT

MIDEAS MYB

7.62e-0350492SM00717
Domain-

UBE2J1 BIRC6

7.92e-03514923.10.110.10
DomainGrowth_fac_rcpt_

HMCN2 LAMA3 SVEP1

7.95e-03156493IPR009030
DomainSushi

CSMD1 SVEP1

8.22e-0352492PF00084
DomainSANT/Myb

MIDEAS MYB

8.22e-0352492IPR001005
DomainEFh

NECAB2 CAPS CALML6

8.23e-03158493SM00054
DomainUBQ-conjugating_enzyme/RWD

UBE2J1 BIRC6

8.53e-0353492IPR016135
DomainCCP

CSMD1 SVEP1

8.85e-0354492SM00032
Pubmed

The characteristics of allelic polymorphism in killer-immunoglobulin-like receptor framework genes in African Americans.

KIR3DL3 KIR2DL4

6.07e-06350221607693
Pubmed

Three structurally and functionally divergent kinds of promoters regulate expression of clonally distributed killer cell Ig-like receptors (KIR), of KIR2DL4, and of KIR3DL3.

KIR3DL3 KIR2DL4

6.07e-06350215778373
Pubmed

Partial duplication of chromosome 19 associated with syndromic duane retraction syndrome.

KIR3DL3 KIR2DL4

1.21e-05450223952617
Pubmed

Ontogeny of arterial macrophages defines their functions in homeostasis and inflammation.

TNFRSF11A MYB

2.02e-05550232917889
Pubmed

Developmental origin, functional maintenance and genetic rescue of osteoclasts.

TNFRSF11A MYB

2.02e-05550230971820
Pubmed

Expression of a killer cell receptor-like gene in plastic regions of the central nervous system.

KIR3DL3 KIR2DL4

4.23e-05750215748957
Pubmed

Identification of the mouse killer immunoglobulin-like receptor-like (Kirl) gene family mapping to chromosome X.

KIR3DL3 KIR2DL4

4.23e-05750212618911
Pubmed

The diversity of KIR gene in Chinese Northern Han population and the impact of donor KIR and patient HLA genotypes on outcome following HLA-identical sibling allogeneic hematopoietic stem cell transplantation for hematological malignancy in Chinese people.

KIR3DL3 KIR2DL4

4.23e-05750218347914
Pubmed

A population-based cohort study of KIR genes and genotypes in relation to cervical intraepithelial neoplasia.

KIR3DL3 KIR2DL4

5.64e-05850215730517
Pubmed

Polymorphisms of killer cell immunoglobulin-like receptor gene: possible association with susceptibility to or clearance of hepatitis B virus infection in Chinese Han population.

KIR3DL3 KIR2DL4

7.25e-05950218074414
Pubmed

Distribution of KIR genes in the Czech population.

KIR3DL3 KIR2DL4

7.25e-05950218186800
Pubmed

Quantitative proteomic profiling of the extracellular matrix of pancreatic islets during the angiogenic switch and insulinoma progression.

HMCN2 LAMA3 DMBT1 SSPOP

1.19e-0417550428071719
Pubmed

[Polymorphism of killer cell immunoglobulin-like receptor gene and its correlation with leukemia].

KIR3DL3 KIR2DL4

1.32e-041250217490516
Pubmed

Frequencies of killer immunoglobulin-like receptor genotypes influence susceptibility to spontaneous abortion.

KIR3DL3 KIR2DL4

1.82e-041450219875891
Pubmed

The laminin alpha chains: expression, developmental transitions, and chromosomal locations of alpha1-5, identification of heterotrimeric laminins 8-11, and cloning of a novel alpha3 isoform.

LAMA3 MYB

1.82e-04145029151674
Pubmed

Distribution of killer cell immunoglobulin-like receptor genes in the Chinese Han population.

KIR3DL3 KIR2DL4

1.82e-041450215896204
Pubmed

[Genotype and haplotype analysis of killer cell immunoglobulin-like receptors in ankylosing spondylitis].

KIR3DL3 KIR2DL4

1.82e-041450219489269
Pubmed

Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia.

KIR3DL3 KIR2DL4

1.82e-041450218945962
Pubmed

Killer cell immunoglobulin-like receptor gene diversity in a Caucasian population of southern Brazil.

KIR3DL3 KIR2DL4

2.10e-041550220082646
Pubmed

Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.

KIR3DL3 KIR2DL4

2.10e-041550220643584
Pubmed

KIR genes polymorphism in Argentinean Caucasoid and Amerindian populations.

KIR3DL3 KIR2DL4

2.10e-041550217498266
Pubmed

Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.

KIR3DL3 KIR2DL4

2.10e-041550219326408
Pubmed

Disparate distribution of activating and inhibitory killer cell immunoglobulin-like receptor genes in patients with systemic lupus erythematosus.

KIR3DL3 KIR2DL4

2.10e-041550219926642
Pubmed

[Killer cell immunoglobin-like receptor and its ligand gene polymorphisms in Hunan Han patients with type 1 diabetes].

KIR3DL3 KIR2DL4

2.10e-041550220356536
Pubmed

Killer cell immunoglobulin-like receptor gene-cluster 3DS1-2DL5-2DS1-2DS5 predisposes susceptibility to Vogt-Koyanagi-Harada syndrome in Japanese individuals.

KIR3DL3 KIR2DL4

2.40e-041650219897003
Pubmed

Influence of activating and inhibitory killer immunoglobulin-like receptors on predisposition to recurrent miscarriages.

KIR3DL3 KIR2DL4

2.40e-041650219279038
Pubmed

No association of KIR genes with Behcet's disease.

KIR3DL3 KIR2DL4

2.40e-041650217868255
Pubmed

A study of the killer cell immunoglobulin-like receptor gene KIR2DS1 in a Caucasoid Brazilian population with psoriasis vulgaris.

KIR3DL3 KIR2DL4

2.40e-041650218643961
Pubmed

Distribution of killer cell immunoglobulin-like receptor (KIR) genotypes in patients with familial Mediterranean fever.

KIR3DL3 KIR2DL4

2.40e-041650219309280
Pubmed

Diversity of killer cell immunoglobulin-like receptor genes in Indonesian populations of Java, Kalimantan, Timor and Irian Jaya.

KIR3DL3 KIR2DL4

2.40e-041650219000141
Pubmed

Diversity of killer cell immunoglobulin-like receptor genes in Indonesian populations of Sumatra, Sulawesi and Moluccas Islands.

KIR3DL3 KIR2DL4

2.40e-041650220670355
Pubmed

Activating killer cell immunoglobulin-like receptor genes' association with recurrent miscarriage.

KIR3DL3 KIR2DL4

2.40e-041650219527230
Pubmed

Report from the killer immunoglobulin-like receptor (KIR) anthropology component of the 15th International Histocompatibility Workshop: worldwide variation in the KIR loci and further evidence for the co-evolution of KIR and HLA.

KIR3DL3 KIR2DL4

2.40e-041650220331834
Pubmed

Polymorphisms of KIR gene and HLA-C alleles: possible association with susceptibility to HLA-B27-positive patients with ankylosing spondylitis.

KIR3DL3 KIR2DL4

2.40e-041650220652381
Pubmed

Asian population frequencies and haplotype distribution of killer cell immunoglobulin-like receptor (KIR) genes among Chinese, Malay, and Indian in Singapore.

KIR3DL3 KIR2DL4

2.40e-041650218668235
Pubmed

[Polymorphism of killer cell immunoglobulin-like receptors gene family in Zhejiang Han population].

KIR3DL3 KIR2DL4

2.40e-041650216403292
Pubmed

HLA-DQA1*0505 sharing and killer immunoglobulin-like receptors in sub fertile couples: report from the 15th International Histocompatibility Workshop.

KIR3DL3 KIR2DL4

2.40e-041650220210919
Pubmed

Natural killer cell receptor repertoire and their ligands, and the risk of CMV infection after kidney transplantation.

KIR3DL3 KIR2DL4

2.72e-041750219032228
Pubmed

The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.

KIR3DL3 KIR2DL4

2.72e-041750220173784
Pubmed

The role of killer immunoglobulin-like receptor haplotypes on the outcome of unrelated donor haematopoietic SCT for thalassaemia.

KIR3DL3 KIR2DL4

2.72e-041750220173792
Pubmed

[Analysis of natural killer cell immunoglobulin-like receptor genes in Chinese].

KIR3DL3 KIR2DL4

2.72e-041750219218127
Pubmed

Role of killer cell immunoglobulin-like receptor gene content and human leukocyte antigen-C group in susceptibility to human T-lymphotropic virus 1-associated myelopathy/tropical spastic paraparesis in Peru.

KIR3DL3 KIR2DL4

2.72e-041750220483367
Pubmed

[Effects of killer immunoglobulin-like receptor and human leukocyte antigen class I ligand on the prognosis of related donor hematopoietic stem cell transplantation].

KIR3DL3 KIR2DL4

2.72e-041750219968064
Pubmed

KIR genes and KIR ligands affect occurrence of acute GVHD after unrelated, 12/12 HLA matched, hematopoietic stem cell transplantation.

KIR3DL3 KIR2DL4

2.72e-041750219169284
Pubmed

Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection.

KIR3DL3 KIR2DL4

2.72e-041750220878400
Pubmed

Killer cell immunoglobulin-like receptor gene diversity in the Tibetan ethnic minority group of China.

KIR3DL3 KIR2DL4

2.72e-041750220650299
Pubmed

Killer cell immunoglobulin-like receptor gene polymorphisms in patients with leukemia: possible association with susceptibility to the disease.

KIR3DL3 KIR2DL4

2.72e-041750219450876
Pubmed

Distribution of killer-cell immunoglobulin-like receptor genes in Eastern mainland Chinese Han and Taiwanese Han populations.

KIR3DL3 KIR2DL4

2.72e-041750219761533
Pubmed

Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.

KIR3DL3 KIR2DL4

3.05e-041850219046302
Pubmed

Effect of killer immunoglobulin-like receptors in the response to combined treatment in patients with chronic hepatitis C virus infection.

KIR3DL3 KIR2DL4

3.05e-041850219846535
Pubmed

Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis.

KIR3DL3 KIR2DL4

3.05e-041850219630074
Pubmed

Influence of HLA class I and HLA-KIR compound genotypes on HIV-2 infection and markers of disease progression in a Manjako community in West Africa.

KIR3DL3 KIR2DL4

3.05e-041850220519398
Pubmed

Signatures of natural selection and coevolution between killer cell immunoglobulin-like receptors (KIR) and HLA class I genes.

KIR3DL3 KIR2DL4

3.05e-041850220200544
Pubmed

Association of killer cell immunoglobulin-like receptors and human leukocyte antigen-C genotypes in South Brazilian with type 1 diabetes.

KIR3DL3 KIR2DL4

3.05e-041850220580654
Pubmed

Distribution of killer cell immunoglobulin-like receptor genes in the mestizo population from Venezuela.

KIR3DL3 KIR2DL4

3.05e-041850220210918
Pubmed

SUMOylation of DDX39A Alters Binding and Export of Antiviral Transcripts to Control Innate Immunity.

UBE2J1 NECAB2 CAPS TNFRSF11A SHROOM2 KCNH4 MYB

3.18e-0491550732393512
Pubmed

Association between killer-cell immunoglobulin-like receptor genotypes and leprosy in Brazil.

KIR3DL3 KIR2DL4

3.41e-041950218778326
Pubmed

KIR and HLA gene combinations in Vogt-Koyanagi-Harada disease.

KIR3DL3 KIR2DL4

3.41e-041950218571006
Pubmed

Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with solid tumors.

KIR3DL3 KIR2DL4

3.41e-041950220600442
Pubmed

Killer cell immunoglobulin-like receptor gene diversity in a Southern Brazilian population from the state of Paraná.

KIR3DL3 KIR2DL4

3.41e-041950218848853
Pubmed

HLA and KIR frequencies in Sicilian Centenarians.

KIR3DL3 KIR2DL4

3.79e-042050220426625
Pubmed

Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay.

KIR3DL3 KIR2DL4

3.79e-042050220193031
Pubmed

Activating killer cell immunoglobulin-like receptors 3DS1 and 2DS1 protect against developing the severe form of recurrent respiratory papillomatosis.

KIR3DL3 KIR2DL4

4.18e-042150219861144
Pubmed

A novel gene family NBPF: intricate structure generated by gene duplications during primate evolution.

NBPF4 NBPF6

4.18e-042150216079250
Pubmed

Distribution of KIR genes in the population of unrelated individuals homozygous for ancestral haplotype AH8.1 (HLA-A1B8DR3).

KIR3DL3 KIR2DL4

4.59e-042250220492596
Pubmed

Prediction of the coding sequences of unidentified human genes. IX. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.

DLG5 SSPOP LCMT2

4.73e-041055039628581
Pubmed

In Vitro Identification of Histatin 5 Salivary Complexes.

DMBT1 CA6

6.95e-042750226544073
Pubmed

Immunogenetic characteristics of patients with autoimmune gastritis.

KIR3DL3 KIR2DL4

8.02e-042950220082482
Pubmed

Novel protein interactions with endoglin and activin receptor-like kinase 1: potential role in vascular networks.

UBE2J1 DLG5 RIPK2

8.04e-0412650324319055
Pubmed

A genome-wide association study of behavioral disinhibition.

MROH7 CSMD1

8.59e-043050223942779
Pubmed

Genome-wide association study of lung function decline in adults with and without asthma.

CSMD1 SVEP1

9.77e-043250222424883
Pubmed

Role of human leukocyte antigen, killer-cell immunoglobulin-like receptors, and cytokine gene polymorphisms in leptospirosis.

KIR3DL3 KIR2DL4

1.17e-033550219683555
Cytoband6q15

UBE2J1 MDN1

5.30e-04315026q15
CytobandEnsembl 112 genes in cytogenetic band chr7q36

VIPR2 ZNF746 SSPOP

7.09e-04159503chr7q36
CytobandEnsembl 112 genes in cytogenetic band chr6q15

UBE2J1 MDN1

1.43e-0351502chr6q15
Cytoband1p13.3

NBPF4 NBPF6

2.60e-03695021p13.3
Cytoband7q36.1

ZNF746 SSPOP

2.99e-03745027q36.1
GeneFamilyCD molecules|Killer cell immunoglobulin like receptors

KIR3DL3 KIR2DL4

6.11e-0418372620
GeneFamilyNeuroblastoma breakpoint family

NBPF4 NBPF6

1.00e-0323372662
GeneFamilyUbiquitin conjugating enzymes E2

UBE2J1 BIRC6

3.18e-0341372102
GeneFamilyGATA zinc finger domain containing|Myb/SANT domain containing

MIDEAS MYB

5.26e-0353372532
GeneFamilyHyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing

CSMD1 SVEP1

6.06e-03573721179
GeneFamilyADAM metallopeptidase domain containing|CD molecules

CD7 KIR3DL3 TNFRSF11A KIR2DL4

8.32e-03394374471
GeneFamilyEF-hand domain containing

NECAB2 CAPS CALML6

1.01e-02219373863
CoexpressionNABA_ECM_GLYCOPROTEINS

HMCN2 LAMA3 DMBT1 SSPOP SVEP1

2.87e-05191495MM17059
CoexpressionNABA_ECM_GLYCOPROTEINS

HMCN2 LAMA3 DMBT1 SSPOP SVEP1

3.24e-05196495M3008
ToppCellPrimary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

HGFAC NECAB2 LAMA3 GRIN2D PCDH8 SVEP1

6.09e-08185506cefd81adb480c027545a5c78dcd05669783717f4
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

HGFAC NECAB2 LAMA3 GRIN2D PCDH8 SVEP1

7.36e-08191506764c3a8829ae1253a0790744138266e81fc075ec
ToppCell5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

DLG5 LAMA3 CSMD1 PPP1R13L UCN2

1.34e-061705050cc20322cb3e3e7bbd4daad8785c99f80e355c16
ToppCell5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

DLG5 LAMA3 CSMD1 PPP1R13L UCN2

1.34e-061705052d880223d01bde4bf777bd6f50b7d2768489075f
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1-3_PAX6_NABP1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

VIPR2 HGFAC NECAB2 PCDH8 SVEP1

1.46e-061735050d38206e25434386b1aec2078067efc67b496c10
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

HGFAC LAMA3 GRIN2D PCDH8 SVEP1

1.55e-06175505e78bf0c33a741bb97e987e41ac33da9e623a08ec
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1-3_PAX6_NABP1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

VIPR2 HGFAC NECAB2 PCDH8 SVEP1

1.55e-06175505f7f8c16e81b26748a5323d70c542d06c02eccdff
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

HGFAC HMCN2 LAMA3 GRIN2D PCDH8

1.82e-0618150535bcdcd2651149692e5b150e887c0f450c81d2d4
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-4_VIP_DSEL|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

HGFAC HMCN2 LAMA3 PCDH8 UCN2

1.82e-0618150570eff83dd85691e977972c660731394d2fcf5cdf
ToppCellNeuronal-Inhibitory-iA-iA_3(VIP)-VIP_3|Neuronal / cells hierarchy compared to all cells using T-Statistic

HGFAC LAMA3 GRIN2D PCDH8 SVEP1

2.97e-062005057e51715525fdb001b7042b2bfcb9de81ecb5e4ee
ToppCellfrontal_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_ALM_Ptrf|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

IGFN1 NECAB2 CD7 KCNH4

1.51e-05133504a1bc34e5dda4ff4716b857931cc196f6770f58f4
ToppCellMS-CD4-CD8_2|MS / Condition, Cell_class and T cell subcluster

CD7 TMPRSS7 PPP1R13L CA6

2.36e-0514950408fb6be5599c5988890c851ce5ac6781c319948e
ToppCellIIF-Lymphocyte-T_NK-NK_CD56bright|IIF / Disease, Lineage and Cell Type

CD7 TNFRSF11A KIR2DL4 CALML6

3.20e-05161504b1bd1074ecba4cf171d748e2f686e9a99c0f0e89
ToppCell390C-Lymphocytic-NK_cells-NK_cell_B2|390C / Donor, Lineage, Cell class and subclass (all cells)

VIPR2 CD7 KIR3DL3 KIR2DL4

3.36e-05163504036e65de0f8fc391f3e4d299bf4c05ee5c3b5a37
ToppCell10x5'-blood-Lymphocytic_NK-NK_CD56bright_CD16-|blood / Manually curated celltypes from each tissue

CD7 TNFRSF11A KIR2DL4 PPP1R13L

3.61e-05166504ba42349a68b22e91a0340bda1ccecd6c7592392f
ToppCellPCW_05-06-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung

CD7 TNFRSF11A KCNH4 MYB

3.87e-0516950445ac692a0c9064ce6b6a31c2cd21c85ccf594670
ToppCellPCW_05-06-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC-im_natural_killer_[NK]_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung

CD7 TNFRSF11A KCNH4 MYB

3.87e-051695043514a74980c7bd4bb76dbd06693f492e8dce21e0
ToppCellfrontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Chat_Htr1f|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

NECAB2 HMCN2 LAMA3 PCDH8

4.05e-05171504f9ae7964a3740f559431125c17c660549798cccc
ToppCellmetastatic_Brain-B_lymphocytes-Undetermined|B_lymphocytes / Location, Cell class and cell subclass

TCAF2 CD7 KIR2DL4 MYB

4.05e-051715040d14bc9688c427ba2265984987dc3eea195b19eb
ToppCellPrimary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1-3_PAX6_NABP1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

VIPR2 HGFAC NECAB2 SVEP1

4.14e-051725044ae0a3ba4660fc9292b7e9a3087a25a3349d8965
ToppCellPrimary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

HMCN2 GRIN2D PCDH8 SVEP1

4.73e-051785043c973aac16988e88f5677d3d695dd772ccfd6570
ToppCellPrimary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-6_VIP_RGS16|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

LAMA3 GRIN2D PCDH8 SVEP1

4.84e-05179504ac94d4c32402c9b856fab656ac1aff0ee12d152c
ToppCellSomatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-6_VIP_RGS16|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

HMCN2 LAMA3 GRIN2D PCDH8

4.84e-051795045bf191bdc0c32bce83ab5c38f0616e209e420e55
ToppCellPrimary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

LAMA3 GRIN2D PCDH8 SVEP1

4.94e-05180504c6030e725e3d86d5d74a1676330c77ffeceb324f
ToppCellprimary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

HGFAC NECAB2 PCDH8 SVEP1

5.05e-0518150403a303cd2f366f09c18b118bbba6f5e3f95ad56c
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-2_VIP_PPAPDC1A|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

HGFAC HMCN2 LAMA3 PCDH8

5.05e-0518150442f5a645beeb5a1a746d79ea7fe7fd3786fd35ad
ToppCellPrimary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

HGFAC NECAB2 PCDH8 SVEP1

5.05e-051815048fd64404e57c22c204d835fc5626f73554257b19
ToppCellprimary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

HGFAC LAMA3 GRIN2D PCDH8

5.16e-051825043d7a8d2ee2137b098248597058974ef5ae09c19e
ToppCellSomatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

HGFAC NECAB2 LAMA3 GRIN2D

5.16e-05182504420a8fd30543e37a66ba0786215d056d308660d0
ToppCellSomatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

LAMA3 GRIN2D PCDH8 SVEP1

5.38e-0518450432473dbdb2de66391157c5814ef34e790806e4f2
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

HGFAC NECAB2 GRIN2D PCDH8

5.50e-05185504487fa382232564f075960899d50afa0edae5d258
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

HGFAC NECAB2 PCDH8 SVEP1

5.50e-0518550479cff4f3c6ae8e5ea60e8eae082b9275f2679ee9
ToppCellPrimary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

HGFAC NECAB2 GRIN2D PCDH8

5.50e-05185504bdfa8c284bbc5e85c806327fbb7778cf16242a38
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

LAMA3 GRIN2D PCDH8 SVEP1

5.50e-051855040b5a0df58ae2ad8261f40f152775747af4f3937a
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_VIP_PRSS8|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

HGFAC NECAB2 LAMA3 PCDH8

5.50e-051855044c42bd3cd72f91f4d4ebb849069a03761a2cd662
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-6_VIP_RCN1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

HGFAC NECAB2 LAMA3 PCDH8

5.50e-05185504538db481c82b02e5d3b8e03b166f754cc936901e
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_VIP_PRSS8|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

HGFAC NECAB2 LAMA3 PCDH8

5.61e-05186504fef543f188edb0d1704d9c6ace366a0f8017bf53
ToppCellfacs-Brain_Non-Myeloid-Cortex-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

IGFN1 CD7 CSMD1 KCNH4

5.61e-051865047278a1a1bf9bb27aeb03852134defb31b62f30d6
ToppCellprimary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

HGFAC LAMA3 GRIN2D PCDH8

5.73e-05187504ae2ee6f8e5c37cb88a67f3e742cf86e57657bfaf
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

HGFAC NECAB2 PCDH8 SVEP1

5.73e-05187504d2ffb2f34f07b0dd5d3cb3ee0275f46ebecf4146
ToppCellprimary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

LAMA3 GRIN2D PCDH8 SVEP1

5.85e-051885046ee3f8f94ea7bdf652c9575fc65bff08070093a4
ToppCellPrimary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

LAMA3 GRIN2D PCDH8 SVEP1

5.85e-05188504c66fccdfe68760b8c3efca77e3c25966dc9a8a5f
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

HGFAC NECAB2 PCDH8 SVEP1

5.85e-05188504ee572246e0c2f41bdbc29a03edc67b831af95c09
ToppCell10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic_-_developing-thymocyte|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

VIPR2 RIPK2 LAMA3 MYB

5.85e-05188504bcfc426b60d8e5a23a2360bfb68b32868fec9fbf
ToppCellHippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Nts_(Neuron.Slc17a6.Nts)-|Hippocampus / BrainAtlas - Mouse McCarroll V32

CD7 TMPRSS7 KCNH4

5.88e-0567503bc06a697f47b60c43e238f8c6803a1b061f22550
ToppCellHippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Nts_(Neuron.Slc17a6.Nts)|Hippocampus / BrainAtlas - Mouse McCarroll V32

CD7 TMPRSS7 KCNH4

5.88e-056750350acd69659f6d827868dc48bfb00af8634a8b4c7
ToppCell(1)_T_CD8_gd|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)

VIPR2 CD7 KIR3DL3 KIR2DL4

5.97e-0518950462eda4bcfd21d5025ac676d524994ede22721c1d
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

HGFAC NECAB2 LAMA3 GRIN2D

6.22e-051915047b386512284dfaa0e95358b28ee82632ee965e64
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_GGH|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

LAMA3 GRIN2D PCDH8 SVEP1

6.22e-0519150406760c3bb40e4f66879a5f5e09c9abfce4ebbba3
ToppCell10x5'-lymph-node_spleen-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|lymph-node_spleen / Manually curated celltypes from each tissue

VIPR2 CD7 KIR3DL3 KIR2DL4

6.22e-05191504f802a4686ecf00e8302047bfe23356f24b266cf8
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

HGFAC LAMA3 GRIN2D PCDH8

6.35e-051925043abee376c37c3646da33ac381aa63d50a01607a6
ToppCell10x5'-lymph-node_spleen-Lymphocytic_T_CD4/8-lo|lymph-node_spleen / Manually curated celltypes from each tissue

VIPR2 CD7 KIR3DL3 KIR2DL4

6.35e-051925044d72b9264ed62e0c08cde4078061b348253f6989
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

LAMA3 GRIN2D PCDH8 SVEP1

6.35e-05192504025fac36b862f9ca7f96fb4a1946c44ba7cbc382
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

LAMA3 GRIN2D PCDH8 SVEP1

6.35e-051925046a252e298f8a454623fa9c1c893a7a45a886d694
ToppCellfrontal_cortex-Neuronal-GABAergic_neuron-Meis2-Meis2_Adamts19|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

VIPR2 HGFAC SVEP1

6.43e-0569503130b1a56afe6aee01cde56cb983cbc2c41861bb4
ToppCellfrontal_cortex-Neuronal-GABAergic_neuron-Meis2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

VIPR2 HGFAC SVEP1

6.43e-05695036568fcefcc0dca211f2acf6e4066f795489e758d
ToppCell3'_v3-blood-Lymphocytic_NK-NK_CD56bright_CD16-|blood / Manually curated celltypes from each tissue

INTS6 CD7 TNFRSF11A KIR2DL4

6.74e-051955041470f562ebcfe7da367964ecfd6c7f43bcdb4a73
ToppCellmild_COVID-19-NK|World / disease group, cell group and cell class (v2)

VIPR2 INTS6 CD7 KIR2DL4

7.15e-05198504c0334e31772ab691be29cbaa78e43ee3b00425f5
ToppCell5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

VIPR2 HMCN2 PCDH8 SVEP1

7.15e-0519850412cd9f0bbad8dce5199ebfed1c4a8080710ca055
ToppCelldistal-Hematologic-Natural_Killer-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

VIPR2 CD7 KIR3DL3 KIR2DL4

7.29e-05199504d663335f267efc42c83cde128a31b3b2e0792764
ToppCellNeuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-HS3ST3A1|Neuronal / cells hierarchy compared to all cells using T-Statistic

LAMA3 GRIN2D PCDH8 SVEP1

7.44e-05200504dd68ce6934eafb75d918042fcf7fd7a750294b7f
ToppCellNeuronal-Inhibitory-iA-iA_3(VIP)-VIP_2-TYR-L2-5|Neuronal / cells hierarchy compared to all cells using T-Statistic

HGFAC HMCN2 LAMA3 PCDH8

7.44e-0520050404954fbe1e2264077228bb582c9a5897a70e6da2
ToppCellNeuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR|Neuronal / cells hierarchy compared to all cells using T-Statistic

HGFAC NECAB2 LAMA3 GRIN2D

7.44e-05200504862db57d043bdf3cb059fbfc8b29bc1eafdf64ec
ToppCellNeuronal-Inhibitory-iA|Neuronal / cells hierarchy compared to all cells using T-Statistic

HGFAC NECAB2 LAMA3 GRIN2D

7.44e-052005045ef4a3dc18a44292184a59ced916183c0699b01e
ToppCellNeuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR--L1|Neuronal / cells hierarchy compared to all cells using T-Statistic

HGFAC NECAB2 LAMA3 GRIN2D

7.44e-05200504a91345f268f13170c27309333603eb82400c9947
ToppCellNeuronal-Inhibitory-iA-iA_3(VIP)-VIP_2-SERPINF1|Neuronal / cells hierarchy compared to all cells using T-Statistic

HGFAC HMCN2 LAMA3 PCDH8

7.44e-05200504c4e08cf539c12bb7c61be6d44b4f074bb460f526
ToppCellNeuronal-Inhibitory-iA-iA_3(VIP)-VIP_2|Neuronal / cells hierarchy compared to all cells using T-Statistic

HGFAC HMCN2 LAMA3 PCDH8

7.44e-05200504913487e065dd580c9cbcbb3c3fc76a8d446f8856
ToppCellNeuronal-Inhibitory-iA-iA_3(VIP)-VIP_2-TYR|Neuronal / cells hierarchy compared to all cells using T-Statistic

HGFAC HMCN2 LAMA3 PCDH8

7.44e-05200504bfdafb024a7b20d46837b2e6480dd4929253cd62
ToppCellNeuronal-Inhibitory-iA-iA_3(VIP)-VIP_2-SERPINF1-L2-5|Neuronal / cells hierarchy compared to all cells using T-Statistic

HGFAC HMCN2 LAMA3 PCDH8

7.44e-05200504f922f9f223cbfed71b8e3115b16b51dc4d7b66b8
ToppCellNeuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR-|Neuronal / cells hierarchy compared to all cells using T-Statistic

HGFAC NECAB2 LAMA3 GRIN2D

7.44e-05200504d416a7be1a4e6232fb58a9687774da24821f1fdd
ToppCellNeuronal-Inhibitory-iA-iA_3(VIP)|Neuronal / cells hierarchy compared to all cells using T-Statistic

HGFAC LAMA3 GRIN2D PCDH8

7.44e-0520050475649534a98bc738fca62d071de0978dc61eb24f
ToppCellNeuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-HS3ST3A1-L3-6|Neuronal / cells hierarchy compared to all cells using T-Statistic

LAMA3 GRIN2D PCDH8 SVEP1

7.44e-0520050406ea96428728199a30a0f836647d6448287d3848
ToppCellThalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Slc17a6-Inhibitory_Neuron.Slc17a6-Gad1Gad2.Asb4_(Periventricular_Fiber_System_(Pv))|Thalamus / BrainAtlas - Mouse McCarroll V32

IGFN1 UCN2 KCNH4

1.61e-049450382e9178c848468497295c4cc59c662b9279208a1
ToppCellThalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Slc17a6-Inhibitory_Neuron.Slc17a6-Gad1Gad2.Asb4_(Periventricular_Fiber_System_(Pv))-|Thalamus / BrainAtlas - Mouse McCarroll V32

IGFN1 UCN2 KCNH4

1.61e-0494503be1dcfe287f58d608ccdb47cf9c1d12b5e3aa60d
ToppCellThalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Slc17a6|Thalamus / BrainAtlas - Mouse McCarroll V32

IGFN1 UCN2 KCNH4

1.61e-0494503576c37fa53fab679f5e8786f5c798e18998186e9
ToppCellCerebellum-Macroglia-ASTROCYTE-Gja1-Gfap+_astrocytes_(Gfap)--|Cerebellum / BrainAtlas - Mouse McCarroll V32

MROH7 TMPRSS7 PPP1R13L

2.77e-04113503fed408864201218295bac0cc6647953fda8d688e
ToppCellCerebellum-Macroglia-ASTROCYTE-Gja1-Gfap+_astrocytes_(Gfap)-|Cerebellum / BrainAtlas - Mouse McCarroll V32

MROH7 TMPRSS7 PPP1R13L

2.77e-04113503c0b8d7a2e3722029e850051bdff77f31f34a8cca
ToppCellCerebellum-Macroglia-ASTROCYTE-Gja1-Gfap+_astrocytes_(Gfap)|Cerebellum / BrainAtlas - Mouse McCarroll V32

MROH7 TMPRSS7 PPP1R13L

2.77e-041135037e24c0f6a80e10a2a41325d48a87628bd330a1e2
ToppCellCOVID-19_Mild-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients

NBPF4 KIR2DL4 SVEP1

3.64e-041245035ef9eb806fb2c8ee5aae0a75503d244b08ee10d4
ToppCellPBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

NBPF4 MROH7 SVEP1

3.82e-0412650369b2525b92d1c7c35b21cc701f5fa52a9c1b94bb
ToppCellPBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

NBPF4 MROH7 SVEP1

3.82e-041265036cb89754010d64875e115da6c5805efac7a4a82d
ToppCellNS-moderate-d_07-13-Epithelial-unknown_epithelial|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

HGFAC INTS6 TEX14

4.18e-041305031491e8975520e99c527a5b5bee64875d124f7bf4
ToppCellmoderate-Epithelial-unknown_epithelial|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

HGFAC INTS6 CA6

4.18e-04130503a04057bd4f256d09eca06b8c1e8b41425bb4ef3f
ToppCellfrontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Col15a1_Pde1a|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

HGFAC LAMA3 PCDH8

4.18e-0413050356b9c3325e011f1dbaf9efc71bd6e1af4f96fda6
ToppCellLPS-antiTNF-Epithelial_alveolar-Mes-like|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

MDN1 PPP1R13L SVEP1

4.57e-0413450364979e1a056b7406e1be39c5ebe2f8d731ac3c17
ToppCellLPS-IL1RA-Lymphocytic_NKT-T_cells-iNKT-MAIT|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

CD7 KIR2DL4 MYB

4.57e-0413450392981dc68c1b3cdc53f9cf83386c47f0c6c98ae7
ToppCellfacs-Trachea-18m-Hematologic-myeloid-tracheal_macrophage-macrophage_of_trachea|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

IGFN1 SHBG NFAM1

5.09e-0413950396e6fed23e7a69f678f85e8e2fe77a7491586b4b
ToppCellfacs-Marrow-B-cells-24m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CD7 SHBG CSMD1

5.52e-041435036df16bf0324661cd9707df69cb39f4b5498d6d49
ToppCellBac-SEP-Lymphocyte-T_NK-CD8_Naive|Bac-SEP / Disease, Lineage and Cell Type

CD7 HMCN2 CA6

5.64e-04144503fdcf84e8b5fdc0730f243919f9cc30492e24dd75
ToppCellfrontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Crispld2_Htr2c|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

HGFAC LAMA3 PCDH8

5.87e-0414650347368f981180ca6a8c81a50f7f9430f12456f609
ToppCellURO-Lymphocyte-T_NK-NK_CD56bright|URO / Disease, Lineage and Cell Type

CD7 TNFRSF11A KIR2DL4

5.98e-04147503a6ca90e8dc37a016572ff68f34ab227b020eef70
ToppCellLPS-antiTNF-Hematopoietic_Mast-Mast_cells-T-cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

CD7 TNFRSF11A PCDH8

5.98e-041475031ecd7c084e73eb6fae1ab1f9aae17115d3d62cbd
ToppCellBac-SEP-Lymphocyte-T_NK-CD8_TCM|Bac-SEP / Disease, Lineage and Cell Type

MDN1 CD7 TNFRSF11A

6.10e-041485035814bfb5060bac455334eb50d2a7b1f01c0b6831
ToppCellCerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb|Cerebellum / BrainAtlas - Mouse McCarroll V32

GRIN2D TEX14 CSMD1

6.22e-041495036e9ca280a599d96f8956ef26f2a46b9484de5488
ToppCellLPS_only-Hematopoietic_Mast-Mast_cells-T-cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

VIPR2 CD7 TNFRSF11A

6.35e-04150503ccb782fbcb3122266354a112a9a850506664f44d
ToppCellTCGA-Breast|World / Sample_Type by Project: Shred V9

NBPF4 NBPF6 MYB

6.35e-0415050308686ba1acac5c58667bf62e2af84c691d6bbdfb
ToppCellmild_COVID-19_(asymptomatic)-NK_CD56bright|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2)

CD7 TNFRSF11A KIR2DL4

6.47e-041515032470162f4b56bc505db166a6eb0fa54847759df8
ToppCellsevere_COVID-19-NK_CD56bright|World / disease group, cell group and cell class (v2)

CD7 TNFRSF11A KIR2DL4

6.60e-04152503ab5a4e47b23d16018642d4c9c7f41b30205edf73
ToppCellCOVID-19_Severe-CD8+_T_naive|World / disease group, cell group and cell class

CD7 MYB CA6

6.85e-04154503b568417d88a78d8c46688847f0f5f4989bd36387
ToppCellnormal_Pleural_Fluid-Myeloid_cells-Monocytes|Myeloid_cells / Location, Cell class and cell subclass

UBE2J1 RIPK2 NFAM1

6.98e-0415550385eb60d285b8bfc095c341ae90c0e3b7e7dca9c1
Diseasecysteine-glutathione disulfide measurement

VIPR2 NFAM1

1.35e-0411472EFO_0021001
Diseasekiller cell immunoglobulin-like receptor 2DS2 measurement

KIR3DL3 KIR2DL4

2.57e-0415472EFO_0801746
DiseaseQRS duration, response to sulfonylurea

MDN1 CSMD1

6.15e-0423472EFO_0005055, EFO_0007922
Diseasenicotine withdrawal measurement

CSMD1 NFAM1

8.50e-0427472EFO_0009362

Protein segments in the cluster

PeptideGeneStartEntry
RSAPAARWSSQGHHP

AMER3

796

Q8N944
SQGWHRCSDAPPRAS

CD7

136

P09564
TDEPWSEHERHSPNC

BIRC6

341

Q9NR09
EDSHWSGALPHCTGN

CSMD1

2901

Q96PZ7
STVHSCSWAPPHLQR

CAPS

36

Q13938
PWCHHPAESCQTTTD

CALML6

11

Q8TD86
HGSLTTPPCTENVHW

CA6

216

P23280
HRWSPSCENLPTSHQ

MROH7

1291

Q68CQ1
CPQGTWSGDLSHHQS

NBPF4

481

Q96M43
DISRPFGSQPWHSCH

INTS6

251

Q9UL03
HHSWSDSSVGCEQAP

MDN1

511

Q9NU22
WPRAGSFHASFCPHV

LAMA3

1151

Q16787
ECVARGHPSPTLSWH

HMCN2

1646

Q8NDA2
SDRCWSPSCSGPNAH

PCDH8

961

O95206
CSSHPHSPTGWSAPS

KIR3DL3

96

Q8N743
EWAPYSPGHSSRHSN

DLG5

1151

Q8TDM6
HSASPHGPPRCSAAW

KCNH4

791

Q9UQ05
PTQNHTCSYPGWHST

MYB

316

P10242
WVVSAAHCFSHSPPR

HGFAC

441

Q04756
RCRGFHPHSPTEWSA

KIR2DL4

96

Q99706
GQPPPHSTWNCHSLS

MIDEAS

126

Q6PJG2
HTYSHWPSCCPSKGQ

IL25

31

Q9H293
TLSSPCPSAAWHFRH

IGFN1

331

Q86VF2
SCPHNGWLSHNCGHS

DMBT1

1071

Q9UGM3
VNSPDSHGWTPLHCA

PPP1R13L

686

Q8WUF5
GHDSSVNSVCWAPHD

SEC13

101

P55735
HRQGPSASPSCHWDS

TEX14

891

Q8IWB6
CTDAQGHSWAPGSQH

SSPOP

4121

A2VEC9
HWSAWSPCSHSCGPR

SSPOP

4166

A2VEC9
HGWEFPPHTTEATCN

TCAF2

766

A6NFQ2
CPQGTWSGDLSHHRS

NBPF6

481

Q5VWK0
CSVHWPHSTVRGSGT

NFAM1

131

Q8NET5
SGSSPCHSWSPATRR

PPARGC1B

856

Q86YN6
RSHEIWTHSCPQSPG

SHBG

381

P04278
STSGCPSWSGRHHAS

SHROOM2

136

Q13796
QWSSGFPHCEHTSCG

SVEP1

3051

Q4LDE5
EAHCTENGTWSHPVP

SVEP1

3336

Q4LDE5
SHRVPWGSCASASAP

LINC00477

111

Q96M19
HCFHGNRLSDPTPWT

TMPRSS7

646

Q7RTY8
HHCPGNHSWDSTISG

RIPK2

386

O43353
CSGDHVSWHSPLDNS

SUFU

156

Q9UMX1
CLSISGHHPETWQPS

UBE2J1

91

Q9Y385
NEWGCHDLHLTSPSS

UNKL

316

Q9H9P5
SSGTLHCPDQPSSWV

VIPR2

186

P41587
WAAQSHCSPTRHPGS

UCN2

56

Q96RP3
SWQTDLPPHHPSSAC

ZNF746

251

Q6NUN9
PEARHSHSACTWQGG

LCMT2

531

O60294
AWVHSLTGASSCPAP

TEX13B

256

Q9BXU2
VDSGHCPHWAASPSP

TNFRSF11A

426

Q9Y6Q6
GSTFWSHPFNSLCHP

NMD3

296

Q96D46
PRSGPAAWHCRHCAS

GRIN2D

1171

O15399
SHSAAQTWCGSPTPA

NECAB2

206

Q7Z6G3